Abstract:Nowadays, nonviral gene transfer is currently of great importance for introducing exogenous genes into genomes and for ensuring that transgene expression is suitable for therapeutic and bioproduction purposes. The piggyBac transposon-based system is particularly interesting since it is easy to engineer and has a large cargo capacity, up to 100 kb. In its setup, the system requires only the piggyBac transposase protein and the transgene delineated by the two piggyBac-specific inverted terminal repeats. Usually the source of transposase is carried by a DNA plasmid. However, the principal drawback of this method is the lasting presence of the transposase, due to episomal persistence or possible integration of the transposase gene vector into the cell's genome. This can lead to genotoxic effects such as multiple genomic integration events and remobilization of the transposon vector once it has been integrated. One alternative to improve the safety of the system is to deliver the transposase as in vitro-synthesized messenger RNA in order to define a very narrow expression window during which a one-shot transposition process would occur. Issues that can be encountered when working on mRNA cell transfer are related to the quality of the synthetic mRNA, the system used to introduce mRNA into the cells and the bioavailability of the mRNA molecules. Here we describe a method to produce mRNA, verify its quality, determine which transfecting reagents can be used and how this mRNA is available to promote the transposition process in HeLa cells. Additionally, we illustrate this method in stromal mesenchymal cell lines in order to support hematopoiesis.

Experimental considerations for precise RNA-mediated insertion of transgenes

Harnessing eukaryotic retroelement proteins for transgene insertion into human safe-harbor loci

Structure and sequence at an RNA template 5' end influence insertion of transgenes by an R2 retrotransposon protein

Plant Transposon and the Application in Functional Genomics

All-RNA-mediated targeted gene integration in mammalian cells with rationally engineered R2 retrotransposons

A retrotransposon for site-specific gene transfer

RNA-guided retargeting of Sleeping Beauty transposition in human cells

Stable expression of large transgenes via the knock-in of an integrase-deficient lentivirus

Inkjet-mediated Gene Transfection into Living Cells Combined with Targeted Delivery.

Discovery and Engineering of Retrons for Precise Genome Editing

In Vitro Synthesis, Delivery, and Bioavailability of Exogenous mRNA in Gene Transfer Mediated by PiggyBac Transposition

Precision Transcriptome Editing

Inkjet Gene Printing: A Novel Approach to Achieve Gene Modified Cells for Tissue Engineering

Template-jumping prime editing enables large insertion and exon rewriting in vivo

A Transfection-Free Approach of Gene Editing via a gold-based nanoformulation of the Cas9 protein

Improvement in Tol2 transposon for efficient large-cargo capacity transgene applications in cultured cells and zebrafish ( Danio rerio)

Transposase-assisted target-site integration for efficient plant genome engineering

Precise cut-and-paste DNA insertion using engineered type V-K CRISPR-associated transposases

CRISPR-Enabled Autonomous Transposable Element (CREATE) for RNA-based gene editing and delivery

An enhanced Eco1 retron editor enables precision genome engineering in human cells from a single-copy integrated lentivirus

Structures of vertebrate R2 retrotransposon complexes during target-primed reverse transcription and after second strand nicking